Lomitapide Mesylate
Overview
Lomitapide Mesylate is an inhibitor of microsomal triglyceride transfer protein and is used as an adjunct to a low-fat diet and other lipid-lowering treatments for the prevention and chronic management of hyperlipidemia. It reduces levels of cholesterol by limiting the secretion of triglyceride-rich lipoproteins into the bloodstream.
API suppliers (1)
Suppliers of Lomitapide Mesylate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
Therapeutic areas
Do you supply Lomitapide Mesylate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.